Dicerna, MDRNA, City of Hope National Medical Center deal

MDRNA disclosed in its 4Q08 earnings that it returned its rights to the center's IP. MDRNA (formerly Nastech Pharmaceutical Co. Inc.) had an exclusive license to Dicer Substrate IP for use with five undisclosed targets, as well as non-exclusive rights to use the IP against all other mammalian targets (see BioCentury, Nov. 13, 2006). ...